发明名称 |
Glucose inducible insulin expression and methods of treating diabetes |
摘要 |
The invention provides an isolated tissue specific glucose responsive promoter having a polymerase binding domain 3' to at least one tripartite transcription factor binding cis element having a hepatocyte nuclear factor-1 (HNF-1) element, a CAAT/enhancer binding protein (C/EBP) response element and a glucose-response element (GRE). The promoter can include a second or third tripartite transcription factor binding cis element. A host cell including the tissue specific glucose responsive promoter of the invention also are provided. Further provided is a method of treating or preventing diabetes. The method includes administering to an individual an effective amount of a viral particle having a vector comprising a tissue specific glucose responsive promoter comprising a polymerase binding domain 3' to at least one tripartite transcription factor binding cis element having a hepatocyte nuclear factor-1 (HNF-1) element, a CAAT/enhancer binding protein (C/EBP) response element and a glucose-response element (GRE) operationally linked to an insulin encoding nucleic acid, wherein expression of the insulin encoding nucleic acid is tissue specific and glucose responsive.
|
申请公布号 |
US2007020237(A1) |
申请公布日期 |
2007.01.25 |
申请号 |
US20060443575 |
申请日期 |
2006.05.30 |
申请人 |
BIOTECH INSTITUTE FOR INTERNATIONAL INNOVATION, INC. |
发明人 |
YOON CHUNGJA;YOON JI-WON;HAN JAESEOK |
分类号 |
C12N5/08;A61K48/00;C12N15/86 |
主分类号 |
C12N5/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|